SynX integrates four core technology modules, building a complete R&D-to-manufacturing closed loop spanning material design, AI prediction, high-throughput screening, and continuous-flow production.
GreenMatrix · Material Library
100+ Green Material Systems, Covering monomers/crosslinkers、lipids/lipidoids、polymers/ three core domains, for AI Model Provides ~100K CandidatesMaterials training foundation.
OpenGMater · AI Engine
Delivery Foundation Model, Encodes formulation-process-property-application into a unified "delivery language", Multi-Agent Parallel Reasoning, Driving intelligent design of liposomes/NPs/microcapsules.
A delivery material library of ~100K candidates spanning three core domains — monomers/crosslinkers, lipids/lipidoids, and polymers/natural wall materials — unlocking a design space of millions of micro/nano carrier formulations.
100+
Green Material Systems
~100K
Candidates Encoded
3
Core Material Domains Monomers · Lipids · Polymers
20+ Years
Cumulative R&D Experience
Differentiation: Unlike traditional trial-and-error material development, GreenMatrix encodes complete material-process-property-application data into unified tokens, enabling AI models to systematically search and optimize across millions of formulation possibilities — dramatically compressing the cycle from material discovery to formulation validation.
Pillar 02 · AI Foundation Model
OpenGMater · Delivery Foundation Model
Encoding the GreenMatrix library, process data, and characterization results into a unified "delivery language," building a foundation model for drug delivery that drives intelligent design of millions of micro/nano carrier formulations.
"Speed is the ultimate weapon": OpenGMater transforms formulation design from empirical trial-and-error to model-driven discovery. Input payload, target, and dosage form requirements → the model generates candidate formulations → agents auto-execute dispensing and characterization → data returns in real time → the model learns and recommends the next experiment. This "dry-wet experiment flywheel" achieves order-of-magnitude efficiency gains in delivery system R&D.
A proprietary, world-class automated ultra-high-throughput microfluidic platform with 5 functional modules enabling high-throughput preparation and in-line screening of LNPs, polymeric nanoparticles, microcapsules, and microspheres.
μL
-Level Sample Consumption Ultra-Low Material Cost
5
Functional Modules Full Automation
Real-Time
In-line Detection Size · PDI · Encapsulation
4
Formulation Systems LNP · NP · MC · MS
Vision-Guided Droplet Manipulation: A proprietary vision recognition model enables precise micro-droplet manipulation and high-throughput screening, with AI-based real-time analysis of particle size distribution and morphology — automatically flagging optimal formulations and feeding back to OpenGMater for the next design iteration. The dry-wet experiment cycle compresses from "weeks per round" to "multiple rounds per day."
Pillar 04 · Manufacturing
SynShell™ · Modular Continuous-Flow Manufacturing
A proprietary modular continuous-flow manufacturing platform covering four major process systems: LNPs, polymeric nanoparticles, microcapsules, and microspheres. Core logic: rather than simply "scaling up reactors," SynShell achieves this through parallel scale-up, continuous feeding, and in-line detection — faithfully replicating micro-scale mixing conditions.
Traditional Scale-Up Pain Points · Scale-up reactors → Uneven mixing · Widening PSD, increasing PDI · Reduced encapsulation efficiency · Uncontrolled batch-to-batch variation · Long process development cycles
GreenMatrix™ — 100+ Green Material Systems, Three Core Domains（Monomers/crosslinkers、lipids/lipidoids、polymers/natural wall materials）, ~100K Candidates Encoded as Unified Tokens, Unlocking a million-scale formulation design space.
Screen · AI + Microfluidics
OpenGMater delivery foundation model + ultra-high-throughput microfluidics platform — from formulation generation to μL-level rapid screening to real-time data feedback, the dry-wet experiment flywheel achieves order-of-magnitude efficiency gains.
Manufacture · Translation
SynShell™ Continuous-Flow Mfg — Four major process systems, parallel scale-up replaces traditional stepwise amplification, seamless path from lab to GMP. 5 hospital validations, 3 national-level programs.
We are not betting on any single drug — we are systematically building the delivery systems that make all next-generation therapeutics work better. From small-molecule sustained release to nucleic acid targeting to live biotherapeutics, SynX covers the full spectrum of delivery technology. We stand among the few global platforms integrating both micro- and nano-scale capabilities, with AI and ultra-high-throughput microfluidics as our engines to expand the frontiers of drug delivery.